Delucemine
Alternative Names: NPS 1506Latest Information Update: 23 Feb 2011
At a glance
- Originator NPS Pharmaceuticals
- Class Neuroprotectants; Small molecules
- Mechanism of Action Glutamate receptor antagonists; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Craniocerebral trauma; Major depressive disorder; Stroke
Most Recent Events
- 24 Jan 2005 Suspended - Phase-I for Depression in USA (unspecified route)
- 24 Feb 2004 Phase-I clinical trials in Depression in USA (unspecified route)
- 20 Oct 2003 Preclinical trials in Depression in USA (unspecified route)